Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
63
BDTX Quote, Financials, Valuation and Earnings
Last price:
$3.22
Seasonality move
:
-29.92%
Day range:
$3.05 - $3.26
52-week range:
$1.20 - $6.75
Dividend yield:
0%
P/E ratio:
53.50x
P/S ratio:
--
P/B ratio:
1.29x
Volume:
988.2K
Avg. volume:
1.3M
1-year change:
-46.05%
Market cap:
$182.5M
Revenue:
--
EPS (TTM):
$0.06
Earnings Data
Next earnings date for BDTX
Aug 06
2025
Most recent earnings per share
$0.98
Beat by $1.24
(May 12/2025)
Consensus Estimate
-$0.26
(May 12/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
BDTX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | -- | -- | -- | -$0.23 | -- |
| 08/06/2025 | Q2 | -- | -- | -- | -$0.23 | -- |
| 05/12/2025 | Q1 | $17.5M | $70M | $0.98 | -$0.26 | $1.24 |
| 03/06/2025 | Q4 | -- | -- | -$0.28 | -$0.31 | $0.03 |
| 11/05/2024 | Q3 | -- | -- | -$0.28 | -$0.36 | $0.08 |
| 08/06/2024 | Q2 | -- | -- | -$0.36 | -$0.39 | $0.03 |
| 05/09/2024 | Q1 | -- | -- | -$0.35 | -$0.43 | $0.08 |
| 03/12/2024 | Q4 | -- | -- | -$0.34 | -$0.46 | $0.12 |
| 11/06/2023 | Q3 | -- | -- | -$0.45 | -$0.49 | $0.04 |
| 08/11/2023 | Q2 | -- | -- | -$0.52 | -$0.52 | $0.00 |
| 05/09/2023 | Q1 | -- | -- | -$0.57 | -$0.61 | $0.04 |
| 03/17/2023 | Q4 | -- | -- | -$0.59 | -$0.61 | $0.02 |
| 11/08/2022 | Q3 | -- | -- | -$0.60 | -$0.62 | $0.02 |
| 08/09/2022 | Q2 | -- | -- | -$0.63 | -$0.67 | $0.04 |
| 05/11/2022 | Q1 | -- | -- | -$0.70 | -$0.74 | $0.04 |
| 03/17/2022 | Q4 | -- | -- | -$0.71 | -$0.98 | $0.27 |
| 11/08/2021 | Q3 | -- | -- | -$0.97 | -$0.95 | -$0.02 |
| 08/12/2021 | Q2 | -- | -- | -$0.95 | -$0.88 | -$0.07 |
| 05/07/2021 | Q1 | -- | -- | -$0.84 | -$0.65 | -$0.19 |
| 03/25/2021 | Q4 | -- | -- | -$0.63 | -$0.61 | -$0.02 |
| 11/10/2020 | Q3 | -- | -- | -$0.50 | -$0.50 | $0.00 |
| 08/11/2020 | Q2 | -- | -- | -$0.41 | -$0.39 | -$0.02 |
| 05/12/2020 | Q1 | -- | -- | -$0.51 | -$0.49 | -$0.02 |
| 03/24/2020 | Q4 | -- | -- | -$0.30 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$0.66 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -$0.88 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$0.27 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$0.22 | -- | -- |
Black Diamond Therapeutics Earnings Questions
-
How Much did Black Diamond Therapeutics Generate in Revenue Last Quarter?
Black Diamond Therapeutics reported $70M worth of top line sales in its most recent quarter.
-
Did Black Diamond Therapeutics Beat Earnings Last Quarter?
Black Diamond Therapeutics announced earnings per share of $0.98 which represents a beat of analyst forecast a -$0.26 per share.
-
Is Black Diamond Therapeutics Profitable?
Black Diamond Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Black Diamond Therapeutics EPS Next Year?
Black Diamond Therapeutics's earnings are forecast to decrease from -$1.27 per share to -$1.27 per share next year representing a decrease of -54.86%.
-
When is Black Diamond Therapeutics's Earnings Date?
Black Diamond Therapeutics's next earnings date is August 6, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 18
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
